MLAB Stock Overview
Develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 6/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Mesa Laboratories, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$100.86 |
| 52 Week High | US$141.17 |
| 52 Week Low | US$83.68 |
| Beta | 0.86 |
| 11 Month Change | -24.73% |
| 3 Month Change | -25.75% |
| 1 Year Change | 14.78% |
| 33 Year Change | -68.01% |
| 5 Year Change | -57.12% |
| Change since IPO | 3,193.39% |
Recent News & Updates
Investors Give Mesa Laboratories, Inc. (NASDAQ:MLAB) Shares A 25% Hiding
Nov 20
We Think Mesa Laboratories (NASDAQ:MLAB) Can Stay On Top Of Its Debt
Oct 17Recent updates
Investors Give Mesa Laboratories, Inc. (NASDAQ:MLAB) Shares A 25% Hiding
Nov 20We Think Mesa Laboratories (NASDAQ:MLAB) Can Stay On Top Of Its Debt
Oct 17A Piece Of The Puzzle Missing From Mesa Laboratories, Inc.'s (NASDAQ:MLAB) 27% Share Price Climb
Jul 29Is Now An Opportune Moment To Examine Mesa Laboratories, Inc. (NASDAQ:MLAB)?
May 03Is Mesa Laboratories (NASDAQ:MLAB) Using Too Much Debt?
Mar 15Mesa Laboratories, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Feb 08Is Mesa Laboratories, Inc. (NASDAQ:MLAB) Trading At A 43% Discount?
Dec 05Is Mesa Laboratories (NASDAQ:MLAB) A Risky Investment?
Sep 28Estimating The Intrinsic Value Of Mesa Laboratories, Inc. (NASDAQ:MLAB)
Aug 09We Think Mesa Laboratories (NASDAQ:MLAB) Is Taking Some Risk With Its Debt
Jun 28Investor Optimism Abounds Mesa Laboratories, Inc. (NASDAQ:MLAB) But Growth Is Lacking
May 31A Look At The Intrinsic Value Of Mesa Laboratories, Inc. (NASDAQ:MLAB)
Apr 12Does Mesa Laboratories (NASDAQ:MLAB) Have A Healthy Balance Sheet?
Mar 13Estimating The Fair Value Of Mesa Laboratories, Inc. (NASDAQ:MLAB)
Dec 20Mesa Laboratories declares $0.16 dividend
Oct 03Mesa Laboratories: Softening Bottom Line Fundamentals, Fairly Priced
Sep 09Are Investors Undervaluing Mesa Laboratories, Inc. (NASDAQ:MLAB) By 41%?
Sep 06Does Mesa Laboratories (NASDAQ:MLAB) Have A Healthy Balance Sheet?
Aug 08Mesa Laboratories GAAP EPS of -$0.27 misses by $0.27, revenue of $50.45M misses by $1.72M
Aug 04Mesa Laboratories declares $0.16 dividend
Jul 07Shareholder Returns
| MLAB | US Life Sciences | US Market | |
|---|---|---|---|
| 7D | -3.6% | -5.8% | -1.0% |
| 1Y | 14.8% | 1.7% | 30.3% |
Return vs Industry: MLAB exceeded the US Life Sciences industry which returned 1.7% over the past year.
Return vs Market: MLAB underperformed the US Market which returned 30.3% over the past year.
Price Volatility
| MLAB volatility | |
|---|---|
| MLAB Average Weekly Movement | 7.7% |
| Life Sciences Industry Average Movement | 8.8% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.7% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: MLAB has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: MLAB's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1982 | 736 | Gary Owens | www.mesalabs.com |
Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries.
Mesa Laboratories, Inc. Fundamentals Summary
| MLAB fundamental statistics | |
|---|---|
| Market cap | US$535.48m |
| Earnings (TTM) | -US$245.65m |
| Revenue (TTM) | US$228.38m |
2.4x
P/S Ratio-2.2x
P/E RatioIs MLAB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MLAB income statement (TTM) | |
|---|---|
| Revenue | US$228.38m |
| Cost of Revenue | US$83.26m |
| Gross Profit | US$145.12m |
| Other Expenses | US$390.77m |
| Earnings | -US$245.65m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -45.23 |
| Gross Margin | 63.54% |
| Net Profit Margin | -107.56% |
| Debt/Equity Ratio | 127.0% |
How did MLAB perform over the long term?
See historical performance and comparisonDividends
0.6%
Current Dividend Yield-1%
Payout RatioDoes MLAB pay a reliable dividends?
See MLAB dividend history and benchmarks| Mesa Laboratories dividend dates | |
|---|---|
| Ex Dividend Date | Nov 29 2024 |
| Dividend Pay Date | Dec 16 2024 |
| Days until Ex dividend | 7 days |
| Days until Dividend pay date | 24 days |
Does MLAB pay a reliable dividends?
See MLAB dividend history and benchmarks